U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H31NO10
Molecular Weight 529.5357
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 13-DEOXYDOXORUBICIN

SMILES

[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]2C[C@](O)(CCO)CC3=C(O)C4=C(C(=O)C5=C(OC)C=CC=C5C4=O)C(O)=C23

InChI

InChIKey=RGVRUQHYQSORBY-JIGXQNLBSA-N
InChI=1S/C27H31NO10/c1-11-22(30)14(28)8-17(37-11)38-16-10-27(35,6-7-29)9-13-19(16)26(34)21-20(24(13)32)23(31)12-4-3-5-15(36-2)18(12)25(21)33/h3-5,11,14,16-17,22,29-30,32,34-35H,6-10,28H2,1-2H3/t11-,14-,16-,17-,22+,27-/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H31NO10
Molecular Weight 529.5357
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

13-deoxyadriamycin hydrochloride (13-Deoxydoxorubicin hydrochloride, GPX-100) is an anthracycline similar to doxorubicin. GPX-100 is unique among anthracyclines because it is not converted to doxorubicinol during metabolism in the body. This metabolite has been shown to be a major cause of damage to the heart (cardiotoxicity) in laboratory studies. GPX-100 belongs to the class of reactive oxygen species stimulants; RNA synthesis inhibitors and Type II DNA topoisomerase inhibitors. It was in phase II clinical trial for the treatment of cancer.

Approval Year

PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

Breast Cancer: Dosage Form - IV solution of sterilized lyophilized powder in Sodium Chloride (NaCl) for Injection, USP (0.9%). Doses - 140 mg/m2 GPX-100 with escalation to 170 mg/m2 and de-escalation to 105 mg/m2 depending upon clinical response and toxicity. Administration - One IV infusion every 3 weeks for up to 8 doses.
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:49:58 GMT 2023
Edited
by admin
on Sat Dec 16 11:49:58 GMT 2023
Record UNII
1S9VO1DQG5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
13-DEOXYDOXORUBICIN
Common Name English
GPX-100
Code English
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(2-HYDROXYETHYL)-1-METHOXY-, (8R,10S)-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C1594
Created by admin on Sat Dec 16 11:49:58 GMT 2023 , Edited by admin on Sat Dec 16 11:49:58 GMT 2023
Code System Code Type Description
DRUG BANK
DB05706
Created by admin on Sat Dec 16 11:49:58 GMT 2023 , Edited by admin on Sat Dec 16 11:49:58 GMT 2023
PRIMARY
FDA UNII
1S9VO1DQG5
Created by admin on Sat Dec 16 11:49:58 GMT 2023 , Edited by admin on Sat Dec 16 11:49:58 GMT 2023
PRIMARY
CAS
628290-43-7
Created by admin on Sat Dec 16 11:49:58 GMT 2023 , Edited by admin on Sat Dec 16 11:49:58 GMT 2023
PRIMARY
NCI_THESAURUS
C2494
Created by admin on Sat Dec 16 11:49:58 GMT 2023 , Edited by admin on Sat Dec 16 11:49:58 GMT 2023
PRIMARY
PUBCHEM
9829419
Created by admin on Sat Dec 16 11:49:58 GMT 2023 , Edited by admin on Sat Dec 16 11:49:58 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT